Dr. Everett C. Ribakove, MD

Dr. Ribakove practices at UNC Health Southeastern in Lumberton, North Carolina.

Dr. Ribakove's NPI, 1609863810, was assigned on October 3, 2005. Dr. Ribakove graduated from Albany Medical College in 1994. Dr. Ribakove's North Carolina license number on file is 200101123.

Dr. Ribakove's primary practice is UNC Health Southeastern, at 300 West 27th Street 3 East, Lumberton, NC 28358. The practice phone is (910) 735-8576.

Dr. Ribakove's primary practice is UNC Health Southeastern in Lumberton, North Carolina. Dr. Ribakove is also affiliated with UNC Health Southeastern. The medical group on file is UNC Physicians Network. Dmand AI also links Dr. Ribakove to 2 more hospitals, 5 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ribakove practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ribakove's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ribakove is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ribakove's licenses on file in 6 states: North Carolina, South Carolina, Virginia, Wyoming, Tennessee and Georgia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lung cancer, lymphoma, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Ribakove treats.

CMS data shows 188 Medicare services from Dr. Ribakove across 4 procedure codes in 2024, all of them office visits, for 67 Medicare patients. Medicare paid $18,080 for them.

CMS counts 67 Medicare patients who saw Dr. Ribakove in 2024. The largest group is 75 to 84, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ribakove's median patient age at 72, with 62% women.

In 2024, Dr. Ribakove wrote 492 Medicare Part D claims for 90 patients. 80% of them were for generic drugs. CMS names the drug for 319 of them, across 15 drugs with 11 or more claims each, at $76,107 in total drug cost. In 2023, CMS named 39 claims across 3 drugs.

Dr. Ribakove accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Ribakove to 7 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Carcinoma, Intraductal, Noninfiltrating. SWOG Cancer Research Network sponsors the most, 3.

CMS Open Payments shows 86 general payments to Dr. Ribakove from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Jazz Pharmaceuticals Inc. paid the most, $4,868.

Dr. Ribakove graduated from Albany Medical College in 1994.

Dr. Ribakove is in network with 8 carriers, including Excellus BlueCross BlueShield, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.